Last reviewed · How we verify

NCT03907995

Peer-led Group Intervention for Coping With Disaster

Completed NA Last updated 27 May 2020
What this trial tests

NA trial testing Cognitive Behavioral Therapy in Anxiety Disorder in 18 participants. Completed in 31 December 2019.

Timeline
29 May 2019
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorBaylor College of Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment18
Start date29 May 2019
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

18 and older, any sex, with Anxiety Disorder or PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present project partners with leading faith communities in Houston to provide expert-led educational workshops to a diverse sample of adults on normative and concerning response to disaster. Secondly implementing peer-led interventions where a trained adult leads others through an evidence-based manualized intervention. Lastly, identifying and referring individuals who require more intensive services to a higher level of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive Behavioral Therapy

Trials testing the same drug.

Other recruiting trials for Anxiety Disorder

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing